Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (2): 116-120.
Previous Articles Next Articles
LIU Zhi-jun, YUAN Xing-dong, ZHANG Wei, ZHOU Juan, XU Yu-ming*
Received:
2017-08-30
Revised:
2018-03-28
Online:
2018-02-20
Published:
2018-03-28
CLC Number:
LIU Zhi-jun, YUAN Xing-dong, ZHANG Wei, ZHOU Juan, XU Yu-ming. Literature Research and Risk Analysis of Nitrous Oxide Abuse[J]. Chinese Journal of Pharmacovigilance, 2018, 15(2): 116-120.
[1] 王丽, 范其江, 董明睿, 等. 滥用笑气中毒致神经系统损害一例[J]. 中国现代神经疾病杂志, 2016, 16(8): 533-535. [2] Kaar S J, Ferris J, Waldron J, et al. Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use[J]. Journal of Psychopharmacology, 2016, 30(4): 395-401. [3] Beckman N J, Zacny J P, Walker D J. Within-subject comparison of the subjective and psychomotor effects of a gaseous anesthetic and two volatile anesthetics in healthy volunteers[J]. Drug and alcohol dependence, 2006, 81(1): 89-95. [4] Nagele P, Duma A, Kopec M, et al. Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial[J]. Biological psychiatry, 2015, 78(1): 10-18. [5] Binkerd E F, Kolari O E. The history and use of nitrate and nitrite in the curing of meat[J]. Food and cosmetics toxicology, 1975, 13(6): 655-661. [6] Butzkueven H, King J O. Nitrous oxide myelopathy in an abuser of whipped cream bulbs[J]. Journal of clinical neuroscience, 2000, 7(1): 73-75. [7] Maze M, Fujinaga M. Pharmacology of nitrous oxide[J]. Best Practice & Research Clinical Anaesthesiology, 2001, 15(3): 339-348. [8] Sanders R D, Weimann J, Maze M. Biologic Effects of Nitrous OxideA Mechanistic and Toxicologic Review[J]. The Journal of the American Society of Anesthesiologists, 2008, 109(4): 707-722. [9] Gruss M, Bushell T J, Bright D P, et al. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane[J]. Molecular pharmacology, 2004, 65(2): 443-452. [10] Ohashi Y, Guo T, Orii R, et al. Brain stem opioidergic and GABAergic neurons mediate the antinociceptive effect of nitrous oxide in Fischer rats[J]. The Journal of the American Society of Anes-thesiologists, 2003, 99(4): 947-954. [11] Banks R G S, Henderson R J, Pratt J M. Reactions of gases in solution. Part III. Some reactions of nitrous oxide with transition-metal complexes[J]. Journal of the Chemical Society A: Inorganic, Physical, Theoretical, 1968: 25(1), 2886-2889. [12] Frasca V, Riazzi B S, Matthews R G. In vitro inactivation of methionine synthase by nitrous oxide[J]. Journal of Biological Chemistry, 1986, 261(34): 15823-15826. [13] Van Amsterdam J, Nabben T, Van den Brink W. Recreational nitrous oxide use: Prevalence and risks[J]. Regulatory toxicology and pharm-acology, 2015, 73(3): 790-796. [14] Nagele P, Duma A, Kopec M, et al. Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial[J]. Biological psychiatry, 2015, 78(1): 10-18. [15] Leslie K, Myles P S, Chan M T V, et al. Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial[J]. Anesthesia & Analgesia, 2011, 112(2): 387-393. [16] Imberger G, Orr A, Thorlund K, et al. Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis[J]. British journal of anaesthesia, 2014, 112(3): 410-426. [17] Va sman A I. Working conditions in the operating room and their effect on the health of anesthetists[J].Eksperimental'naia khirurgiia i anesteziologiia, 1967, 12(3): 44. [18] McGregor D G, Baden J M, Bannister C, et al. Waste Anesthetic Gases: Information for the Management in Anesthetizing Areas and the Postanesthesia Care Unit (PACU)[J]. Park Ridge, IL: American Society of Anesthesiologists, 1999, 63(1): 22. [19] O'Donovan M R, Hammond T G. Is nitrous oxide a genotoxic carcinogen[J]. Mutagenesis, 2015, 30(4): 459-462. [20] Richardson K J, Shelton K L. N-Methyl-d-Aspartate Receptor Channel Blocker-Like Discriminative Stimulus Effects of Nitrous Oxide Gas[J]. Journal of Pharmacology and Experimental Therapeutics, 2015, 352(1): 156-165. [21] Walker D J, Zacny J P. Analysis of the reinforcing and subjective effects of different doses of nitrous oxide using a free-choice procedure[J]. Drug and alcohol dependence, 2002, 66(1): 93-103. [22] Zacny J P, Lichtor J L, Coalson D W, et al. Time course of effects of brief inhalations of nitrous oxide in normal volunteers[J]. Addiction, 1994, 89(7): 831-839. [23] Jakovljevic M, Vidmar G, Mekjavic I B. Psychomotor function during mild narcosis induced by subanesthetic level of nitrous oxide: Individual susceptibility beyond gender effect[J]. Undersea & Hyperbaric Medicine, 2012, 39(6): 1067. [24] Chiang T T, Hung C T, Wang W M, et al. Recreational nitrous oxide abuse-induced vitamin B12 deficiency in a patient presenting with hyperpigmentation of the skin[J]. Case reports in dermatology, 2013, 5(2): 186-191. [25] Chen H J, Huang C S. Nitrous Oxide-induced Subacute Combined Degeneration Presenting with Dystonia and Pseudoathetosis: A Case Report[J]. Acta Neurologica Taiwanica, 2016, 25(2): 50-55. [26] Mancke F, Kaklauskait G, Kollmer J, et al. Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report[J]. Substance abuse and rehabilitation, 2016, 7(1): 155. [27] Hirvioja J, Joutsa J, Wahlsten P, et al. Recurrent paraparesis and death of a patient with 'whippet'abuse[J]. Oxford medical case reports, 2016, 2016(3): 41-43. [28] Ghodse A H, Corkery J, Ahmed K, et al. Trends in UK deaths associated with abuse of volatile substances, 1971-2009[J]. International Centre for Drug Policy , 2012, 1(24): 22-26. [29] Cheng H M, Park J H, Hernstadt D. Subacute combined degeneration of the spinal cord following recreational nitrous oxide use[J]. BMJ case reports, 2013, 2013(8): 1. [30] Garakani A, Welch A K, Jaffe R J, et al. Psychosis and low cyanocobalamin in a patient abusing nitrous oxide and cannabis[J]. Psychosomatics, 2014, 55(6): 715-719. [31] Winstock A R. The global drug survey 2014. findings[J]. Global Drug Survey, 2014. [32] ACMD. Advisory Council on the Misuse of Drugs (ACMD). Advice on nitrous oxide [EB/OL](2015-03-04)[2017-07-15]. https://www.gov.uk/government/publications/acmd-advice-on-nitrous-oxide-abuse. [33] Nabben T, Benschop A, Korf D J. Antenne 2013: trends in alcohol, tabak en drugs bij jonge Amsterdammers[J]. Rozenberg Publishers, 2014, 97(11): 1, 3-17. [34] Goossens F X, Frijns T, Hasselt N E, et al. Het grote uitgaansonderzoek 2013. Uitgaanspatronen, middelengebruik en risicogedrag onder uitgaande jongeren en jongvolwassenen[J]. Trimbos-instituut, Utrecht, 2013. [35] Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health [EB/OL]. (2015)[2017-07-15]. https://www.icpsr.umich.edu/icpsrweb/SAMHDA/ssvd/studies/35509/datasets/0001/variables/NITOXID?q=NITOXID&series=Nati-onal+Survey+on+Drug+Use+and+Health+%28NSDU H%29+Series&paging.start Row=26. [36] GDS. Global Drug Survey 2015 findings. What did we learn from GDS2015? An overview of our key findings [EB/OL]. [2017-07-16] https://www.globaldrugsurvey.com/the-global-drug-survey-2015-findings/. [37] 王丽. 滥用笑气 青少年身心很受伤[N]. 健康报,2017-07-07(4). |
[1] | ZHANG Qingxia, JIANG Yongxian, DONG Yuexin, XIAN Ying, YAN Suying. Risk analysis and precautions related to storage conditions specified in package inserts of western medicines in a hospital [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 913-918. |
[2] | WANG Dan, WU Chen, REN Jingtian. Risk analysis of dextromethorphan abuse [J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1097-1099. |
[3] | JIANG Yongxian, PU Xinyu, CHEN Wenwen, TAO Wanjun, CHEN Juan, LI Gen. Countermeasures Against Risk of Neonatal Off-label Drug Use [J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 164-169. |
[4] | HUO Yanfei, XIE Yanjun, XU Lili, CHANG Hong, SUN Chunxiao, TIAN Yuejie. 1160 Cases of Adverse Reactions Caused by Compound Liquorice Tablets and Risk Factors [J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1176-1180. |
[5] | HUANG Yuan, WANG Chenggang, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun. Drug Abuse Monitoring Models in Medical Institutions in China [J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 607-612. |
[6] | WANG Jiayu, YU Dandan, LI Ming, WANG Ling, LIU Pengcheng, SUN Jun. Current Abuse/Use of Compound Tramadol in Drug Abusers [J]. Chinese Journal of Pharmacovigilance, 2020, 17(2): 98-105. |
[7] | BAN bingkun, REN pengyu, WEI jingtu, CAO zijing. Course of Development and Status quo of Drug Abuse Monitoring in China [J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 777-779. |
[8] | WU Jianru, XIAO Xiao, LIU Xiaoyu, WANG Shu. Epidemic Characteristics of First-time Drug Abuse and Influencing Factors of Synthetic Drug Abuse among Adolescents in Shenzhen [J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 823-827. |
[9] | LIU Bin, LV Jialin, YIN Ruoyun, ZHOU Juan, HUANG Helang, WU Lei. Risk of Narcotics and Psychotropic Substances Abuse among Drug Abusers [J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 828-832. |
[10] | WANG Chenggang, HUANG Yuan, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun. Survey about Medical Staff's Knowledge of Drug Abuse Monitoring in China [J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 697-702. |
[11] | SUN Jun, YU Dandan, LI Ming, WU Chen, LIU Pengcheng, WANG Jiayu. Analysis of Current Abuse among Drug Abusers in China [J]. Chinese Journal of Pharmacovigilance, 2020, 17(1): 37-44. |
[12] | SUN Zhenhui, SUN Jun, WANG Jiayu, YU Dandan, WANG Ling, YU Zheng. Research on the Status Quo of the Regulation of Compound Tramadol [J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 528-535. |
[13] | SUN Zhenhui, WANG Jiayu, YU Dandan, WANG Ling, YU Zheng. Survey on Gender Differences among Abusers/Users of Compound Tramadol [J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 536-542. |
[14] | YU Dandan, SUN Jun, WANG Jiayu, WU Chen, LIU Pengcheng. Analysis of Factors Influencing Abuse/Use Behavior of Compound Tramadol [J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 543-549. |
[15] | WAN Kaihua, WEI Yu, XU Yuming, ZHOU Juan. Current Status of Drug Abuse Epidemic and Intervention Research in China [J]. Chinese Journal of Pharmacovigilance, 2019, 16(6): 338-341. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||